(Q46526183)

22 December 2017

title

Neuroprotective and neurotrophic effects of long term lithium treatment in mouse brain (English)

1 reference

22 December 2017

author name string

Nciri Riadh

1

1 reference

22 December 2017

Mohamed Salah Allagui

2

1 reference

22 December 2017

Ezzedine Bourogaa

3

1 reference

22 December 2017

Christian Vincent

4

1 reference

22 December 2017

Françoise Croute

5

1 reference

22 December 2017

Abdelfattah Elfeki

6

1 reference

22 December 2017

publication date

4 March 2011

1 reference

22 December 2017

published in

BioMetals

1 reference

22 December 2017

volume

24

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

747-757

1 reference

22 December 2017

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

1 reference

Long-term exposure to low lithium concentrations stimulates proliferation, modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Bcl-2 promotes regeneration of severed axons in mammalian CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Toxicity of lithium to humans and the environment--a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Neurotrophins: roles in neuronal development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

The glamour and gloom of glycogen synthase kinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Effects of low doses of Li carbonate injected into mice. Functional changes in kidney seem to be related to the oxidative status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

The effects of subchronic lithium administration in male Wistar mice on some biochemical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Chronic lithium administration triggers an over-expression of GRP94 stress protein isoforms in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Molecular effects of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

The Wnt/beta-catenin signaling pathway as a target in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

New twist on neuronal insulin receptor signaling in health, disease, and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

Enhancement of neuroprotection and heat shock protein induction by combined prostaglandin A1 and lithium in rodent models of focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9433-6

10.1007/S10534-011-9433-6

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017